Total hip arthroplasty (THA) is highly successful for reducing pain and improving function, providing health-related quality of life benefit. Demand for THA is increasing with associated increase in revision hip surgery. Hip arthroplasty surveillance (long-term follow up) can identify asymptomatically failing THA to prepare for revision surgery, reducing potential for complications or complexity of surgery. However, it is unknown whether the surveillance of THA can be shown to improve the patient outcomes or reduce costs around revision surgery. With the current need to reduce unnecessary health consultations and to show the economic advantages of any service, the purpose of this study is to consider the relative effectiveness of hip arthroplasty surveillance on revision hip arthroplasty. This is a single-centre, observational study in which consecutive patients undergoing aseptic revision of THA over 12 months in a large orthopaedic unit will be considered for participation. Primary outcome measures will be change in each of three valid patientreported scores from pre-operatively to 12 months post-surgery. Secondary outcomes will be the costs of treatment calculated using data obtained from the participants' hospital records and a self-report questionnaire. An exploratory approach will be used to investigate the effect of surveillance on the outcomes of interest. A linear mixed method model will be used to study the change in scores between baseline and 12 months. The economic evaluation will be a cost-utility analysis, which compares the value of alternative interventions by attaching costs to the quality-adjusted life years produced by each intervention.
| INTRODUCTION
Total hip arthroplasty has been shown to be a surgical procedure which decreases pain and improves function for the patient, and has significant health-related quality of life benefit when compared with other procedures (Patel, Pavlou, Mujica-Mota, & Toms, 2015) . The National Joint Registry for England, Wales and Northern Ireland shows a steady increase in the number of procedures undertaken each year (National Joint Registry, 2016) . Revision of a hip replacement is necessary when the primary arthroplasty fails, which can be for one of a number of reasons. Early failure of a joint replacement may be the result of infection in the joint (septic) or an aseptic cause such as dislocation, component failure or adverse response of the host body to the implanted material, particularly in metal on metal articulations. These conditions will be accompanied by symptoms that will prompt the patient to seek medical help. Mid-term and late failure occur 5 years or more from the primary surgery and may be due to late infection, which will be accompanied by symptoms, but more often are aseptic in nature and asymptomatic until the later stages. The causes include debonding of the components from the host bone with subsequent instability, or wear of the components with production of wear debris.
This wear debris can disrupt bone metabolism leading to destruction of bone around the hip replacement (osteolysis), predisposing the patient to periprosthetic fracture (Harris, 2004; Katz, Wright, Polaris, Harris, & Losina, 2014) .
As the demand for hip arthroplasty increases due to presentation of patients at a younger age, increased life expectancy and a prevalence of obesity, the burden of revision is predicted to rise 31% by 2030 (Patel et al., 2015) . This is associated with significant costs as revision surgery is more expensive to the health service than a primary procedure, the cost being determined by the indication for the surgery.
In 2014, 4% of revision hip surgeries in England, Wales and Northern Ireland were undertaken for infection and 57% for aseptic loosening or lysis (National Joint Registry, 2016) . Vanhegan, Malik, Jayakumar, Ul Islam, and Haddad (2012) calculated that the average cost of revision for infection was £21 937, for peri-prosthetic fracture was £18 185 and for aseptic loosening was £11 897. Although peri-prosthetic fracture can be classified as an aseptic revision, the cost of revision for peri-prosthetic fracture is one-third higher than for aseptic loosening without fracture due to the technical demands, the additional components required and the associated high rate of complications which may affect recovery (da Assuncao et al., 2015) .
The advantage of hip arthroplasty surveillance (long-term follow up) is that it provides screening by specialists who can identify failing joints. Failure of hip replacements due to wear and loosening is radiologically evident but often asymptomatic, meaning that the patient is unaware of change until significant bone loss has occurred. Routine surveillance offers the opportunity to identify asymptomatically failing hip replacements and plan for revision surgery, thus reducing the potential for peri-prosthetic fracture or other complications. In addition to any cost saving at the time of surgery, this is thought to benefit the patient and the orthopaedic surgeon, who would otherwise be faced with a more complex reconstructive process and rehabilitation (Howard, 2009 Surgeons, 2014; Hart, Sabah, Henckel, Lloyd, & Skinner, 2015) . Current guidelines include the use of the ODEP rating, which is a measure of the revision rating of a component based on data supplied by the manufacturing company (Orthopaedic Data Evaluation Panel, 2015) . There is a letter and a number, the former denoting the strength of the evidence and the latter the number of years to which it relates. For instance, an acetabular cup with an ODEP 10A rating means that evidence exists that at least 90% of that specific component are still in situ (in the patient) at 10 years. For a component with an ODEP rating of 10A, it is recommended that a follow up is offered by the orthopaedic team at 1 year, 7 years and three yearly thereafter, with review of X-ray images by a health professional with the required specialist knowledge. For a component that has not achieved the 10A rating, it is recommended that there is annual follow up for the first 5 years, then two yearly up to 10 years and three yearly thereafter of cemented femoral stems, 69% of cementless femoral stems and 43% of acetabular cups had a 10A rating. But, the same report shows that, in 13% of hip replacements, the surgeon had used a femoral component from one manufacturer and an acetabular component from another manufacturer, known as 'mix and match' (National Joint Registry, 2016) . Finally, the results of a recent survey suggest that there is a variety of follow up practice across the UK with only 43% of orthopaedic units offering any form of follow up 5 years after primary surgery (Smith, 2014) .
In the present economic climate, there is a need to reduce unnecessary health consultations and a growing requirement to show the economic advantage of any service that is provided in order to develop a 'leaner' healthcare system (Corbacho, 2015; Fillingham, 2008) . Many members of the orthopaedic community consider that some follow up is of value for hip arthroplasty patients although this is threatened by lack of funding. However, it is still unknown whether routine surveillance of this group of patients has any benefit through improving the patient outcomes at the time of revision surgery or through reduction of the associated costs. The purpose of this study is to consider the relative effectiveness of hip arthroplasty surveillance: Does revision with surveillance have a different outcome to revision without surveillance?
| OBJECTIVES
The primary objective is to investigate if there is a difference in the health-related quality of life after hip revision surgery between patients diagnosed through routine surveillance and those who have not had any form of long-term follow up.
The secondary objective is to determine if there is a difference in the costs of revision hip surgery and early postoperative care between patients diagnosed through routine surveillance and those who have not had any form of long-term follow up.
| MATERIALS AND METHODS

| Study design and duration
This study is a designed to inform a larger study at a later date and will take place at a single centre. It will be an observational study over a 12-month period to compare the relative effectiveness of surveillance or lack of surveillance on revision hip arthroplasty.
| Participants
The criteria that will be applied to the selection of possible participants are shown in Table 1 .
| Comparators 3.3.1 | Revision with surveillance
For the purposes of this study, hip arthroplasty surveillance will be considered as planned orthopaedic review of the hip implant that now requires revision surgery. The review(s) will have taken place at any time in the period that commences 5 years after the primary operation and continues to the present day, and will include an X-ray image of the affected hip. As there are a variety of review intervals in use, all intervals will be included (Smith, 2014) . The patients in this group will be considered as those with surveillance.
| Revision without surveillance
The comparator group will be those patients who are scheduled for revision surgery following an emergency admission, or following a GP referral for problems with the hip implant. They will be considered those with no orthopaedic long-term follow up of their hip arthroplasty and therefore without surveillance.
In some units, patients are selected for review based on their type of implant or associated research funding. It is beyond the scope of this study to consider subgroups of selective follow up, and a pragmatic approach will be adopted of surveillance versus no surveillance.
| Recruitment
Patients will be recruited to this study by one of two routes (Figure 1 ).
The first is for those whose revision hip surgery is planned in advance.
The date of surgery will be obtained from Southmead Hospital approximately 1 month in advance of the date of operation, and the medical record will be screened for inclusion criteria by the principal investigator. Any patient who is deemed to be eligible will subsequently be sent an invitation letter and information leaflet to read at home. When they attend the pre-operative assessment clinic, they will be asked about participation in the study by a designated, named research nurse. If they consent to participate, they will be given the first questionnaire at that time and asked to complete and return it before their surgery using the pre-paid envelope which will be supplied. The second route of recruitment is for those patients who are in hospital and awaiting revision hip surgery following an emergency admission. The names of prospective participants will be obtained by the designated research nurse through liaison with co-researchers who are present in the daily trauma meeting, and she/he will review the medical records (present on the ward) for eligibility. No information will be extracted or recorded if the patient is ineligible. She/he will visit any eligible patient on the ward to describe the study and to leave an information leaflet with the patient. She/he will return at a pre-agreed time to take consent if the patient is willing and able to participate. The pre-operative questionnaire will be completed by the patient any time preceding their surgery, either in paper form with return by pre-paid envelope or by the research nurse recording their verbal responses to the questionnaire. The patient will be offered this option to minimize the burden of participation while awaiting surgery.
| Assignment
The assignment of each patient to one of the two groups will be retrospective, 12 months after their revision hip surgery, and will be based on their medical records. Any uncertainty will be clarified directly with the patient by the principal investigator.
| Intervention
The intervention will consist of questionnaires administered at three time points. The first will be a pre-operative questionnaire; the second will be a health resource use questionnaire at 6 months post-operatively; and the final questionnaire, a repeat of the first questionnaire, will be at 12 months post-operatively.
At the time of completion of the pre-operative questionnaire, details of the participant's name, age, diagnosis and comorbidities will be collected and stored electronically in a spreadsheet within a hospital trust electronic clinical folder. Each participant will be allocated a unique number which will be used for further data collection. Questionnaire response will be recorded against the unique number of each participant on an encrypted laptop computer. No patient identifiable information will leave the hospital site at any time. If any questionnaire is not returned by a participant, a reminder letter will be issued 2 weeks after the anticipated return date of the questionnaire. If there is still no response, an attempt will be made to telephone the patient to request the return of the questionnaire.
The final data will be collected from each participant's medical records 12 months after the revision hip surgery and will take place on hospital premises. These details include the surgical procedure, any additional in-patient costs, length of stay, and out-patient visits before and after the revision surgery. The medical records will be retrieved by an NHS administrator and reviewed by the primary researcher or research nurse. The unique identifier of each participant will be used to record the data on an encrypted computer.
| Concomitant care
The medical care of the patient will be unaffected by this study, which is purely observational.
| STUDY OUTCOMES
| Primary outcome measures
Primary outcome measures will be the change on each of three valid scores, measuring pain and function, activity and quality of life, from pre-operatively to 12 months post-surgery.
The Oxford Hip Score (OHS) is a widely used score consisting of 12 questions (score range from zero, which is poor, to 48, best outcome) and has been shown to be valid and reliable for use in revision hip surgery (Dawson et al., 2001 ). Pain and function (six questions for each) will be analysed separately as it has been shown to be reliable when used in this way and it has been suggested that pain may be more sensitive to change than other measures in the 2 years following revision hip arthroplasty Zampelis, Ornstein, Franzén, & Atroshi, 2014) . The University of Southern California at Los Angeles (UCLA) activity score will be used to measure the change in activity level of each patient. It has been shown to be a simple and reliable measure to use at the time of hip arthroplasty and is freely available for use (Naal, Impellizzeri, & Leunig, 2009) . It consists of ten levels of activity described in words and the patient selects one level to best describe their current state (range from 1 to 10 with a high value representing a more active lifestyle).
To avoid undue patient burden, these questionnaires will not be repeated 6 months post-surgery as the patient will be asked to complete postal versions of two of them (OHS and EQ-5D-3 L) at that time for the national PROMS programme. Our preparatory work with patients and the public has highlighted that a repeat of these questionnaires for study purposes at 6 months often causes confusion and patient overload.
Permission to use each of the scores was obtained from the appropriate organization, before commencement of the study.
| Secondary outcome measures
The secondary outcome measure will be the costs of treatment, as shown in Table 2 . The health costs will be calculated using data obtained from the participants' hospital records and from a self-report questionnaire. The participants will each be given a log book to keep a record of their use of resources over the 6 months after discharge from hospital. A questionnaire will then be sent to their home for completion using the log book at 6 months after surgery. The self-report questionnaire will also be used to collect data that indicate any personal costs (non-prescribed medication and time off work).
The self-report data will only be collected for 6 months for two reasons: (a) it is the time period in which there will be the greatest effect on the participant's lifestyle, and (b) compliance with completion of self-report data will be improved by limiting the time period and reducing the patient burden.
| STATISTICAL ANALYSIS
This is an observational study and we intend to use an exploratory approach to investigate the effect of surveillance or lack of surveillance on the outcomes of interest.
| Primary outcomes
The study of the change in patient-reported outcome scores between baseline and 12-month assessment will be performed with a linear mixed method model to account for repeated measurements within patients. For each outcome score, the main analysis will regress the baseline and 12-month assessment on long-term follow up status, the indicator of assessment time (0 or 12 months) and their interaction.
The confidence intervals and p-value related to this interaction will provide the quantitative findings to determine if there is a difference in the change of recovery between participants with and without surveillance. The analyses will be adjusted for potential confounders including the type of hip replacement.
Depending on the size of the study sample, we will investigate further the impact of both observed and unobserved confounders using a matching technique such as a propensity score method.
| Secondary outcomes
The economic evaluation of health benefits will be performed with a cost-utility analysis, which compares the value of alternative interventions by attaching costs to the quality-adjusted life years (QALY) pro- some disadvantages, such as the inability to capture the patient's experience, the results will be considered in conjunction with planned simultaneous qualitative research study.
| Sample size
This is an observational pilot study and all eligible patients will be included. The group allocation will be retrospective, determined from medical records and patient corroboration. No sample size will be determined in advance as it is unknown what proportion of patients will be eligible and available for each group although existing local data
suggest that approximately 180 patients may be eligible in a 12-month period.
6 | ORGANIZATION
| Monitoring
This study forms one part of a research plan in the National Institute for Health Research 5-year clinical lectureship awarded to the primary researcher. It will be sponsored by the hosting NHS Trust and monitored with reference to the team of experts already in existence for the duration of the research fellowship. Data monitoring will be conducted through bi-monthly meetings between the statistician and the primary researcher, with reference to two of the professors with expertise in this area (health economics and musculoskeletal rehabilitation). In addition, the two patient partners will continue to be invited to comment on all aspects of the study. Due to the combined expertise available from this group, no additional data monitoring committee will be required for this single-centre observational study.
No harm will be caused from participation in this study but withdrawal for any reason, including participant burden, will be recorded, summarized and presented with the results.
| Ethics
Research ethics approval for this study was granted from the NHS 
| Dissemination
The dissemination of the results from this study will include a short written summary for participants (prepared with patient partners), an abstract and poster presentation to be displayed at regional and national conferences of orthopaedic health professionals and researchers, and a paper submitted to an international orthopaedic journal. In addition, social media will be used to support publications and presentations with the support of research administration at the University of the West of England.
| Study status
This study commenced on 11 July 2016 on completion of all statutory requirements.
| DISCUSSION
Many of the orthopaedic community advocate long-term follow up but the effect of hip arthroplasty surveillance on health-related quality of life and health economics at the time of revision hip surgery is unknown at present. It is anticipated that the results of this study will provide information to support the design of a larger, multi-centre study which can investigate the use of surveillance following hip arthroplasty.
Although this is a simple observational study, the burden on patients to complete questionnaires can be significant. The questionnaires in this study have been constructed to minimize this burden and the research nurse will be available to assist participants who are in hospital following an emergency admission and may require help to compete their questionnaires in order to maximize the response rate. This group of patients are important to the outcome of the study but may be asked to participate in more than one research study; consequently, provision has been made to assist them if required. 
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